Richard A. Fair
CIK 1695851 · PRESIDENT AND CEO · last filed 2025-12-12
Richard A. Fair is a PRESIDENT AND CEO who has filed 18 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing, for IMRA, was dated Dec 12, 2025. Across all open-market trades the lifetime net is +$89.8K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
18
$89.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMRA | PRESIDENT AND CEO | — | $17.02 | — | $0 | 1 | 2025-12-12 |
| BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | President and CEO | 11,813 | $0.07 | $884 | $89.8K | 13 | 2022-08-16 |
| Clovis Oncology, Inc. (CLVS) Delisted | Director | — | $0.08 | — | $0 | 4 | 2021-06-11 |
Recent Filings
18 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-12 | IMRA | Grant (A) | — | $0 | EDGAR |
| 2022-08-16 | BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-08-18 | BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-08-16 | BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-11 | Clovis Oncology, Inc. (CLVS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-12-16 | BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-08 | Clovis Oncology, Inc. (CLVS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-19 | BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Buy (P) | +5,000 | $20.0K | EDGAR |
| 2020-02-04 | BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-09-11 | BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Buy (P) | +40,000 | $50.0K | EDGAR |